Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tetraphase Pharmaceu (TTPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 206,916
  • Shares Outstanding, K 51,600
  • Annual Sales, $ 9,670 K
  • Annual Income, $ -114,750 K
  • 36-Month Beta 2.64
  • Price/Sales 21.40
  • Price/Cash Flow N/A
  • Price/Book 1.96

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.60 +11.39%
on 05/24/18
4.49 -10.69%
on 06/15/18
+0.38 (+10.47%)
since 05/22/18
3-Month
2.73 +46.89%
on 03/28/18
4.49 -10.69%
on 06/15/18
+0.80 (+24.92%)
since 03/22/18
52-Week
2.05 +95.61%
on 02/20/18
8.75 -54.17%
on 07/26/17
-3.87 (-49.11%)
since 06/22/17

Most Recent Stories

More News
Detailed Research: Economic Perspectives on Tetraphase Pharmaceuticals, Tech Data, Southern National Bancorp of Virginia, Esterline Technologies, Myers Industries, and Hersha Hospitality Trust -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tetraphase Pharmaceuticals,...

TECD : 84.92 (-0.52%)
MYE : 19.50 (+0.52%)
SONA : 17.60 (+0.69%)
HT : 21.63 (+1.31%)
TTPH : 4.01 (+0.50%)
ESL : 73.30 (+1.31%)
Tetraphase Pharmaceuticals Announces Data from a Pooled Analysis of IGNITE1 and IGNITE4 Phase 3 Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections at the ASM Microbe 2018 Annual Meeting

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, recently...

TTPH : 4.01 (+0.50%)
Tetraphase Pharmaceuticals Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today...

TTPH : 4.01 (+0.50%)
Today's Free Research Reports Coverage on Seattle Genetics and Three More Biotech Stocks

Stock Research Monitor: SLS, TTPH, and RARE

SGEN : 66.85 (+0.36%)
TTPH : 4.01 (+0.50%)
Tetraphase Pharmaceuticals Announces Everest Medicines' Submission of an Investigational New Drug Application for Eravacycline in Complicated Intra-Abdominal Infection to the China Food and Drug Administration

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today...

TTPH : 4.01 (+0.50%)
Tetraphase Pharmaceuticals to Present at the UBS Global Healthcare Conference

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant infections, announced today that its corporate presentation...

TTPH : 4.01 (+0.50%)
Tetraphase Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Highlights

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today...

TTPH : 4.01 (+0.50%)
Recent Analysis Shows Morningstar, Tactile Systems Technology, Allete, Tetraphase Pharmaceuticals, Magellan Health, and Ambarella Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Morningstar, Inc. (NASDAQ:MORN),...

TCMD : 52.55 (-0.70%)
AMBA : 43.24 (-1.01%)
MGLN : 99.30 (+1.12%)
MORN : 132.21 (-0.98%)
ALE : 76.31 (+0.43%)
TTPH : 4.01 (+0.50%)
Blog Exposure - Tetraphase Pharma Announced Data Presentations from IGNITE4 Study at 28th European Congress of Clinical Microbiology and Infectious Diseases

Stock Monitor: Akari Therapeutics Post Earnings Reporting

AKTX : 1.99 (-0.50%)
TTPH : 4.01 (+0.50%)
Tetraphase Pharmaceuticals to Present Data at 28th European Congress of Clinical Microbiology and Infectious Diseases

- Phase 3 IGNITE4 Results in Complicated Intra-Abdominal Infection Recognized as a 'Best Rated Abstract' -

TTPH : 4.01 (+0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade TTPH with:

Business Summary

Tetraphase Pharmaceuticals, Inc. is a life science company engaged in developing and commercializing tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug...

See More

Key Turning Points

2nd Resistance Point 4.20
1st Resistance Point 4.11
Last Price 4.01
1st Support Level 3.84
2nd Support Level 3.66

See More

52-Week High 8.75
Fibonacci 61.8% 6.19
Fibonacci 50% 5.40
Fibonacci 38.2% 4.61
Last Price 4.01
52-Week Low 2.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar